•Investing in life sciences companies, especially in therapeutics and medical/diagnostic products addressing unmet medical
needs and in healthcare services
•Advising US, European, and Asian companies to license their technologies and products in China
•Advising US, European, and Asian companies to acquire operating assets in China and vice versa
•Assisting Chinese companies to transfer technologies and products to US companies for further development
|